Insider Transactions Reported by 20 Insiders of HERON THERAPEUTICS, INC. /DE/

Symbol
HRTX on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

HERON THERAPEUTICS, INC. /DE/ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rubric Capital Management LP 10%+ Owner $37,859,003 +$3,580,838 +10% 15 Oct 2025
Adam Morgan Director $11,602,242 +$2,649,819 +30% 30 Jan 2026
Velan Capital Investment Management LP Other* $9,675,000 30 Jan 2023
Mark Earl Hensley Chief Operating Officer $3,080,000 30 Jan 2026
Barry D. Quart Chief Executive Officer, Director $2,142,511 18 Jan 2023
KEVIN KOTLER Director $1,242,440 22 Feb 2023
Craig A. Collard Chief Executive Officer, Director $1,073,223 31 Jan 2026
Ira Duarte EVP, Chief Financial Officer $747,932 31 Jan 2026
William P. Forbes EVP, Chief Development Officer $730,274 31 Jan 2026
JOHN POYHONEN President & CCO $455,766 13 Apr 2023
David Leslie Szekeres EVP, Chief Operating Officer $418,232 13 Jul 2023
KIMBERLY MANHARD EVP, Drug Development $416,383 13 Apr 2023
Thomas Cusack Director $320,147 30 Jan 2026
Susan Rodriguez Director $292,262 31 Jan 2025
STEPHEN DAVIS Director $249,214 16 Dec 2022
Lisa Peraza VP, Chief Accounting Officer $208,038 19 Jan 2024
Craig Johnson Director $132,255 30 Jan 2026
Waage Christian Director $132,255 30 Jan 2026
Michael Kaseta Director $132,255 30 Jan 2026
Sharmila Dissanaike Director $132,255 30 Jan 2026

Recent Insider Transactions by Companies or Individuals for HERON THERAPEUTICS, INC. /DE/

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.